Key facts
- Petal Surgical’s last known valuation is $40.0M (Aug 2025).
- It has raised $17.7M across 1 recorded rounds; the latest was Early Stage VC ($17.7M) in Aug 2025.
- Notable investors include ShangBay Capital, Eliot Horowitz, Actions Capital, Draper, Eugene Zhang — 11 tracked in total.
- Petal Surgical has filed 1 Form D with the SEC, most recently Aug 2025 ($17.7M sold to 40 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Petal Surgical
Funding rounds
1 roundsAbout Petal Surgical
Developer of a healthcare technology designed to make surgery incisionless through the precise use of focused ultrasound. The company offers focused sound wave technology that targets and breaks down tissue with high accuracy, enabling healthcare providers and outpatient care settings to perform safer, less invasive procedures that the body can naturally clear away.
- Sector
- Healthcare
- HQ
- Redwood City, CA, United States
- Founded
- 2021
- Employees
- 16
- Website
- petalsurgical.com/
- Ownership
- Privately Held (backing)
Petal Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Petal Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Petal Surgical in its N-PORT filings yet. We sweep new filings monthly.